Compare CNDT & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNDT | ANIK |
|---|---|---|
| Founded | 2016 | 1983 |
| Country | United States | United States |
| Employees | 51000 | 235 |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.6M | 200.9M |
| IPO Year | 2016 | 1996 |
| Metric | CNDT | ANIK |
|---|---|---|
| Price | $1.46 | $14.62 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | ★ 1.2M | 59.6K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.16 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,042,000,000.00 | $112,819,000.00 |
| Revenue This Year | $2.01 | $5.98 |
| Revenue Next Year | $4.06 | $7.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $7.90 |
| 52 Week High | $2.98 | $16.24 |
| Indicator | CNDT | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 50.88 | 48.62 |
| Support Level | $1.32 | $13.88 |
| Resistance Level | $1.60 | $15.08 |
| Average True Range (ATR) | 0.09 | 0.49 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 71.23 | 53.11 |
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation, as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments, namely Commercial Industries, which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas, of which the majority of revenue is generated in the United States.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.